3-Year Outcomes After DES/DCS Implantation for Femoropopliteal CTO: The HAWK Study
The HAWK study demonstrated that endovascular therapy using DES or DCS for long CTO in the femoropopliteal artery achieved acceptable 3-year clinical outcomes in real-world practice, while prior EVT and a smaller reference vessel diameter were identified as independent predictors of restenosis, according to a study presented by Dr. Naoki Hayakawa, Asahi General Hospital, in the Late Breaking Clinical Trials session at CVIT 2026.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations